382 related articles for article (PubMed ID: 25644480)
1. Molecular mechanism of poly(vinyl alcohol) mediated prevention of aggregation and stabilization of insulin in nanoparticles.
Rawat S; Gupta P; Kumar A; Garg P; Suri CR; Sahoo DK
Mol Pharm; 2015 Apr; 12(4):1018-30. PubMed ID: 25644480
[TBL] [Abstract][Full Text] [Related]
2. Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles.
Kumar PS; Ramakrishna S; Saini TR; Diwan PV
Pharmazie; 2006 Jul; 61(7):613-7. PubMed ID: 16889069
[TBL] [Abstract][Full Text] [Related]
3. On the design of in situ forming biodegradable parenteral depot systems based on insulin loaded dialkylaminoalkyl-amine-poly(vinyl alcohol)-g-poly(lactide-co-glycolide) nanoparticles.
Packhaeuser CB; Kissel T
J Control Release; 2007 Nov; 123(2):131-40. PubMed ID: 17854938
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanism of improved structural integrity of protein in polymer based microsphere delivery system.
Rawat S; Kohli N; Suri CR; Sahoo DK
Mol Pharm; 2012 Sep; 9(9):2403-14. PubMed ID: 22724678
[TBL] [Abstract][Full Text] [Related]
5. Influence of formulation parameters on the characteristics of poly(D, L-lactide-co-glycolide) microspheres containing poly(L-lysine) complexed plasmid DNA.
Capan Y; Woo BH; Gebrekidan S; Ahmed S; DeLuca PP
J Control Release; 1999 Aug; 60(2-3):279-86. PubMed ID: 10425333
[TBL] [Abstract][Full Text] [Related]
6. Biodegradable triblock copolymer microspheres based on thermosensitive sol-gel transition.
Kwon YM; Kim SW
Pharm Res; 2004 Feb; 21(2):339-43. PubMed ID: 15032317
[TBL] [Abstract][Full Text] [Related]
7. Branched polyesters based on poly[vinyl-3-(dialkylamino)alkylcarbamate-co-vinyl acetate-co-vinyl alcohol]-graft-poly(D,L-lactide-co-glycolide): effects of polymer structure on in vitro degradation behaviour.
Unger F; Wittmar M; Morell F; Kissel T
Biomaterials; 2008 May; 29(13):2007-14. PubMed ID: 18262641
[TBL] [Abstract][Full Text] [Related]
8. PLGA nanoparticles for peroral delivery: How important is pancreatic digestion and can we control it?
Mante A; Heider M; Zlomke C; Mäder K
Eur J Pharm Biopharm; 2016 Nov; 108():32-40. PubMed ID: 27553262
[TBL] [Abstract][Full Text] [Related]
9. Optimization of PLGA nanoparticles formulation containing L-DOPA by applying the central composite design.
Zhou YZ; Alany RG; Chuang V; Wen J
Drug Dev Ind Pharm; 2013 Feb; 39(2):321-30. PubMed ID: 22607101
[TBL] [Abstract][Full Text] [Related]
10. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
Liu Y; Pan J; Feng SS
Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
[TBL] [Abstract][Full Text] [Related]
11. Cellular uptake mechanism and knockdown activity of siRNA-loaded biodegradable DEAPA-PVA-g-PLGA nanoparticles.
Benfer M; Kissel T
Eur J Pharm Biopharm; 2012 Feb; 80(2):247-56. PubMed ID: 22085653
[TBL] [Abstract][Full Text] [Related]
12. Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake.
Sahoo SK; Panyam J; Prabha S; Labhasetwar V
J Control Release; 2002 Jul; 82(1):105-14. PubMed ID: 12106981
[TBL] [Abstract][Full Text] [Related]
13. Controlled release of insulin from PLGA nanoparticles embedded within PVA hydrogels.
Liu J; Zhang SM; Chen PP; Cheng L; Zhou W; Tang WX; Chen ZW; Ke CM
J Mater Sci Mater Med; 2007 Nov; 18(11):2205-10. PubMed ID: 17668296
[TBL] [Abstract][Full Text] [Related]
14. Insulin-S.O (sodium oleate) complex-loaded PLGA nanoparticles: formulation, characterization and in vivo evaluation.
Sun S; Liang N; Piao H; Yamamoto H; Kawashima Y; Cui F
J Microencapsul; 2010; 27(6):471-8. PubMed ID: 20113168
[TBL] [Abstract][Full Text] [Related]
15. Annealing as a tool for the optimization of lyophilization and ensuring of the stability of protein-loaded PLGA nanoparticles.
Fonte P; Lino PR; Seabra V; Almeida AJ; Reis S; Sarmento B
Int J Pharm; 2016 Apr; 503(1-2):163-73. PubMed ID: 26972381
[TBL] [Abstract][Full Text] [Related]
16. A novel approach to prepare insulin-loaded poly(lactic-co-glycolic acid) microcapsules and the protein stability study.
Emami J; Hamishehkar H; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
J Pharm Sci; 2009 May; 98(5):1712-31. PubMed ID: 18855911
[TBL] [Abstract][Full Text] [Related]
17. Antacid co-encapsulated polyester nanoparticles for peroral delivery of insulin: development, pharmacokinetics, biodistribution and pharmacodynamics.
Sharma G; van der Walle CF; Ravi Kumar MN
Int J Pharm; 2013 Jan; 440(1):99-110. PubMed ID: 22227604
[TBL] [Abstract][Full Text] [Related]
18. Surfactant-free, biodegradable nanoparticles for aerosol therapy based on the branched polyesters, DEAPA-PVAL-g-PLGA.
Dailey LA; Kleemann E; Wittmar M; Gessler T; Schmehl T; Roberts C; Seeger W; Kissel T
Pharm Res; 2003 Dec; 20(12):2011-20. PubMed ID: 14725368
[TBL] [Abstract][Full Text] [Related]
19. Preparation of polyethyleneimine incorporated poly(D,L-lactide-co-glycolide) nanoparticles by spontaneous emulsion diffusion method for small interfering RNA delivery.
Katas H; Cevher E; Alpar HO
Int J Pharm; 2009 Mar; 369(1-2):144-54. PubMed ID: 19010405
[TBL] [Abstract][Full Text] [Related]
20. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
